...
search icon
toi-img

Oncology Institute Inc, Common Stock

TOI

NASDAQ

$0.961133

+$0.05

(5.51%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$72.62M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
308.50K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.62
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.13 L
$2.1 H
$0.961133

About Oncology Institute Inc, Common Stock

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameTOISectorS&P500
1-Week Return17.21%-0.03%1.53%
1-Month Return159.84%4.56%4.75%
3-Month Return308.64%1.29%2.77%
6-Month Return113.59%-3.54%12.18%
1-Year Return-49.41%1.59%22.34%
3-Year Return-85.5%13.55%38.91%
5-Year Return-90.09%40.85%80.7%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue155.41M187.51M203.00M252.48M324.24M[{"date":"2019-12-31","value":47.93,"profit":true},{"date":"2020-12-31","value":57.83,"profit":true},{"date":"2021-12-31","value":62.61,"profit":true},{"date":"2022-12-31","value":77.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue125.46M150.64M162.16M200.39M264.67M[{"date":"2019-12-31","value":47.4,"profit":true},{"date":"2020-12-31","value":56.92,"profit":true},{"date":"2021-12-31","value":61.27,"profit":true},{"date":"2022-12-31","value":75.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit29.94M36.88M40.85M52.09M59.57M[{"date":"2019-12-31","value":50.26,"profit":true},{"date":"2020-12-31","value":61.91,"profit":true},{"date":"2021-12-31","value":68.57,"profit":true},{"date":"2022-12-31","value":87.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin19.27%19.67%20.12%20.63%18.37%[{"date":"2019-12-31","value":93.38,"profit":true},{"date":"2020-12-31","value":95.32,"profit":true},{"date":"2021-12-31","value":97.53,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.05,"profit":true}]
Operating Expenses32.59M45.07M86.71M124.10M136.59M[{"date":"2019-12-31","value":23.86,"profit":true},{"date":"2020-12-31","value":33,"profit":true},{"date":"2021-12-31","value":63.48,"profit":true},{"date":"2022-12-31","value":90.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(2.63M)(8.20M)(45.86M)(72.01M)(77.02M)[{"date":"2019-12-31","value":-263475200,"profit":false},{"date":"2020-12-31","value":-819590300,"profit":false},{"date":"2021-12-31","value":-4585800000,"profit":false},{"date":"2022-12-31","value":-7200700000,"profit":false},{"date":"2023-12-31","value":-7701800000,"profit":false}]
Total Non-Operating Income/Expense(6.75K)(6.97M)33.94M77.78M(13.37M)[{"date":"2019-12-31","value":-0.01,"profit":false},{"date":"2020-12-31","value":-8.96,"profit":false},{"date":"2021-12-31","value":43.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.19,"profit":false}]
Pre-Tax Income(2.64M)(14.81M)(11.60M)1.90M(83.10M)[{"date":"2019-12-31","value":-138.56,"profit":false},{"date":"2020-12-31","value":-778.05,"profit":false},{"date":"2021-12-31","value":-609.14,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4364.71,"profit":false}]
Income Taxes1.38M(492.82K)(671.00K)247.00K(36.00K)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-35.63,"profit":false},{"date":"2021-12-31","value":-48.51,"profit":false},{"date":"2022-12-31","value":17.86,"profit":true},{"date":"2023-12-31","value":-2.6,"profit":false}]
Income After Taxes(4.02M)(14.32M)(10.93M)1.66M(83.07M)[{"date":"2019-12-31","value":-242.69,"profit":false},{"date":"2020-12-31","value":-864.29,"profit":false},{"date":"2021-12-31","value":-659.44,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5013.16,"profit":false}]
Income From Continuous Operations(4.02M)(14.32M)(8.34M)152.00K(75.32M)[{"date":"2019-12-31","value":-2645.65,"profit":false},{"date":"2020-12-31","value":-9421.87,"profit":false},{"date":"2021-12-31","value":-5486.78,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-49553.29,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(4.02M)(14.32M)(10.93M)1.66M(83.07M)[{"date":"2019-12-31","value":-242.69,"profit":false},{"date":"2020-12-31","value":-864.29,"profit":false},{"date":"2021-12-31","value":-659.44,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5013.16,"profit":false}]
EPS (Diluted)-(0.02)(0.17)(0.34)(0.92)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1.88,"profit":false},{"date":"2021-12-31","value":-17,"profit":false},{"date":"2022-12-31","value":-34,"profit":false},{"date":"2023-12-31","value":-92,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TOI
Cash Ratio 1.01
Current Ratio 2.49
Quick Ratio 2.27

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TOI
ROA (LTM) -19.42%
ROE (LTM) -125.59%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TOI
Debt Ratio Lower is generally better. Negative is bad. 0.91
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.09

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TOI
Trailing PE NM
Forward PE NM
P/S (TTM) 0.19
P/B 4.63
Price/FCF NM
EV/R 0.39
EV/Ebitda NM

FAQs

What is Oncology Institute Inc share price today?

Oncology Institute Inc (TOI) share price today is $0.961133

Can Indians buy Oncology Institute Inc shares?

Yes, Indians can buy shares of Oncology Institute Inc (TOI) on Vested. To buy Oncology Institute Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TOI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Oncology Institute Inc be purchased?

Yes, you can purchase fractional shares of Oncology Institute Inc (TOI) via the Vested app. You can start investing in Oncology Institute Inc (TOI) with a minimum investment of $1.

How to invest in Oncology Institute Inc shares from India?

You can invest in shares of Oncology Institute Inc (TOI) via Vested in three simple steps:

  • Click on Sign Up or Invest in TOI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Oncology Institute Inc shares
What is Oncology Institute Inc 52-week high and low stock price?

The 52-week high price of Oncology Institute Inc (TOI) is $2.1. The 52-week low price of Oncology Institute Inc (TOI) is $0.13.

What is Oncology Institute Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Oncology Institute Inc (TOI) is 4.63

What is the Market Cap of Oncology Institute Inc?

The market capitalization of Oncology Institute Inc (TOI) is $72.62M

What is Oncology Institute Inc’s stock symbol?

The stock symbol (or ticker) of Oncology Institute Inc is TOI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top